121 – 130 of 153
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial
- Contribution to journal › Article
-
Mark
Regional contribution to ventricular stroke volume is affected on the left side, but not on the right in patients with pulmonary hypertension
- Contribution to journal › Article
-
Mark
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study.
- Contribution to journal › Article
- 2015
-
Mark
Hemodynamic Characteristics Including Pulmonary Hypertension at Rest and During Exercise Before and After Heart Transplantation.
- Contribution to journal › Article
-
Mark
The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial
- Contribution to journal › Article
-
Mark
Outcomes after ABO-incompatible heart transplantation in adults: A registry study.
- Contribution to journal › Article
-
Mark
ABO-Identical Blood Group Matching Has No Survival Benefit for AB Heart Transplant Recipients.
- Contribution to journal › Article
-
Mark
Safety and efficacy of the switch to generic mycophenolate mofetil and tacrolimus in heart-transplant patients.
- Contribution to journal › Article
-
Mark
Immunosuppressive therapies after heart transplantation - The balance between under- and over-immunosuppression.
- Contribution to journal › Article
-
Mark
Mechanical compression during repeated sustained isometric muscle contractions and hyperemic recovery in healthy young males.
- Contribution to journal › Article
